Samuel S Engel
14PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Nov 15, 2021
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes.R Ravi Shankar, Philip Zeitler, Asma Deeb
|May 25, 2021
Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin.Kohei Kaku, Takashi Kadowaki, Yutaka Seino
|Feb 10, 2021
A randomized, placebo-controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin.Yutaka Seino, Kohei Kaku, Takashi Kadowaki
|Jan 29, 2021
A randomized, placebo-controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control.Takashi Kadowaki, Yutaka Seino, Kohei Kaku
|Aug 28, 2020
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency.Annaswamy Raji, Zhi Jin Xu, Raymond L H Lam
|Mar 01, 2019
Progression of glucose-lowering diabetes therapy in TECOS.M Angelyn Bethel, Samuel S Engel, Susanna R Stevens
Pageof 3
Frequent Collaborators
3 joint publications
Taro Okamoto
3 joint publications
Kohei Kaku
2 joint publications
Ira Gantz
2 joint publications
Rury R Holman
2 joint publications
Annaswamy Raji
2 joint publications
R Ravi Shankar
1 joint publications
Anthony P Nunes
1 joint publications
Craig J Currie
1 joint publications
Ron S Newfield
1 joint publications
Sara Jenkins-Jones
